MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer

被引：21

作者：

Tao, Zuo ^{[1
]}

Suo, Huandan ^{[1
]}

Zhang, Lei ^{[1
]}

Jin, Zining ^{[1
]}

Wang, Zhen ^{[1
]}

Wang, Danyu ^{[1
]}

Wu, Ming ^{[1
]}

Peng, Nanxi ^{[1
]}

Zhao, Yujie ^{[1
]}

Chen, Bo ^{[1
]}

机构：

[1] China Med Univ, Hosp 1, Dept Breast Surg, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China

来源：

ONCOTARGETS AND THERAPY | 2020年 / 13卷

关键词：

cancer genome map; breast cancer; MRPL13; clinical significance; MATRIX METALLOPROTEINASES; ANGIOGENESIS; PATHWAY; GROWTH; VEGF; MITOCHONDRIA; ASSOCIATION; INHIBITION; MECHANISMS; PROTEINS;

D O I：

10.2147/OTT.S263998

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Objective: To study the expression of MRPL13 in breast cancer tissues using TCGA database, analyze the correlation between the expression and clinicopathological characteristics of patients, and explore the role of MRPL13 in the development of breast cancer (BC). Methods: The BC mRNA data and clinical information were downloaded from TCGA database. The correlation between MRPL13 expression and clinicopathological parameters was analyzed. Cox regression multivariate analysis was used to explore the factors affecting the prognosis of BC patients. The UALCAN database was used to analyze the expression level of MRPL13 in BC and its relationship with clinical pathological factors. The GSEA method was used to predict the possible regulatory pathways of MRPL13. Immune responses of MRPL13 expression were analyzed using TISIDB and CIBERSORT. Additionally, GEPIA, K-M survival analysis and data from the HPA were used to validate the outcomes. Results: The expression of MRPL13 in BC tissues was significantly higher than normal counterparts, patients with low MRPL13 expression had a better survival prognosis, also indicated an independent prognostic factor. GSEA analysis showed that the regulation of cell migration, positive regulation of endothelial cell migration, and Notch signaling pathway were enriched in tissues with low expression of MRPL13. Additionally, depleting MRPL13 expression inhibited invasion in MCF-10A and MCF-7 cells. Furthermore, PCR showed that MRPL13 affected VEGFA and MMP gene expression. CIBERSORT analysis revealed that the amount of NK cells decreased when MRPL13 expression was high. Conclusion: The expression of MRPL13 mRNA is upregulated in BC tissues, and the expression level of MRPL13 is significantly related to the clinicopathological factors of patients. High MRPL13 expression is a poor prognostic factor for BC, and it can be used as a molecular marker for prognosis judgment and as a potential therapeutic target.

引用

页码：12255 / 12268

页数：14

共 51 条

[11] Roles of the immune system in cancer: from tumor initiation to metastatic progression [J].

Gonzalez, Hugo ;

Hagerling, Catharina ;

Werb, Zena .

GENES & DEVELOPMENT, 2018, 32 (19-20) :1267-1284

[12] Mechanisms of mitochondrial protein import [J].

Gordon, DM ;

Dancis, A ;

Pain, D .

MOLECULAR TRAFFICKING, 2000, 36 :61-73

[13]

Grosso Joseph F, 2013, Cancer Immun, V13, P5

[14] Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis [J].

Guillermet, J ;

Saint-Laurent, N ;

Rochaix, P ;

Cuvillier, O ;

Levade, T ;

Schally, AV ;

Pradayrol, L ;

Buscail, L ;

Susini, C ;

Bousquet, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :155-160

[15] Assembly of the membrane domain of ATP synthase in human mitochondria [J].

He, Jiuya ;

Ford, Holly C. ;

Carroll, Joe ;

Douglas, Corsten ;

Gonzales, Evvia ;

Ding, Shujing ;

Fearnley, Ian M. ;

Walker, John E. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (12) :2988-2993

[16] Identification of estrogen receptor proteins in breast cancer cells using matrix-assisted laser desorption/ionization time of flight mass spectrometry [J].

Heger, Zbynek ;

Rodrigo, Miguel Angel Merlos ;

Krizkova, Sona ;

Zitka, Ondrej ;

Beklova, Miroslava ;

Kizek, Rene ;

Adam, Vojtech .

ONCOLOGY LETTERS, 2014, 7 (05) :1341-1344

[17] Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2 [J].

Hortobagyi, Gabriel N. ;

Chen, David ;

Piccart, Martine ;

Rugo, Hope S. ;

Burris, Howard A., III ;

Pritchard, Kathleen I. ;

Campone, Mario ;

Noguchi, Shinzaburo ;

Perez, Alejandra T. ;

Deleu, Ines ;

Shtivelband, Mikhail ;

Masuda, Norikazu ;

Dakhil, Shaker ;

Anderson, Ian ;

Robinson, Douglas M. ;

He, Wei ;

Garg, Abhishek ;

McDonald, E. Robert, III ;

Bitter, Hans ;

Huang, Alan ;

Taran, Tetiana ;

Bachelot, Thomas ;

Lebrun, Fabienne ;

Lebwohl, David ;

Baselga, Jose .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) :419-U79

[18] Matrix metalloproteinases in cancer [J].

Itoh, Y ;

Nagase, H .

PROTEASES IN BIOLOGY AND MEDICINE, 2002, 38 :21-36

[19] Enhancement of Natural Killer Cell Cytotoxicity by Sodium/Iodide Symporter Gene-Mediated Radioiodine Pretreatment in Breast Cancer Cells [J].

Kim, Hae Won ;

Kim, Jung Eun ;

Hwang, Mi-Hye ;

Jeon, Yong Hyun ;

Lee, Sang-Woo ;

Lee, Jaetae ;

Zeon, Seok Kil ;

Ahn, Byeong-Cheol .

PLOS ONE, 2013, 8 (08)

[20] Mitochondrial ribosomal protein L41 mediates serum starvation-induced cell-cycle arrest through an increase of p21WAF1/CIP1 [J].

Kim, MJ ;

Yoo, YA ;

Kim, HJ ;

Kang, S ;

Kim, YG ;

Kim, JS ;

Yoo, YD .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (02) :1179-1184

← 1 2 3 4 5 6 →